JINAE ARNEKLEV: Open Payments
NPI 1033158902 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 12 payments from 8 companies in 2025. Trend: 2023 $20,031 · 2024 $2,236 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $239 |
| Hologic Sales and Service, LLC | 1 | $148 |
| Corcept Therapeutics | 1 | $125 |
| Eisai Inc. | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $121 |
| Lilly USA, LLC | 1 | $97 |
| Tanabe Pharma America, Inc. | 3 | $81 |
| GlaxoSmithKline, LLC. | 2 | $41 |
Products named: APTIMA, FARXIGA, Korlym, Leqembi, Kerendia, BREZTRI, ZEPBOUND, Radicava.
Industry payments across MD — which companies pay providers there.
